Abstract
BackgroundPsoriatic arthritis (PsA) is a chronic inflammatory arthritis, characterized by different clinical manifestations and associated comorbidities that requires targeted treatment. Therapy with Tumor necrosis factor inhibitor (TNFi) represents one of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
